Predeposit Autologous Plasma Donation in Liver Resection for Hepatocellular Carcinoma: Toward Allogenic Blood-Free Operations

Journal of the American College of Surgeons

Volumn 209, Issue 2, 2009, Pages 206-214

  Ishizawa, Takeaki ^a   Hasegawa, Kiyoshi ^a   Tsuno, Nelson Hirokazu ^b   Tanaka, Minoru ^b   Mise, Yoshihiro ^a   Aoki, Taku ^a   Imamura, Hiroshi ^a   Beck, Yoshifumi ^a   Sugawara, Yasuhiko ^a   Makuuchi, Masatoshi ^c   Takahashi, Koki ^b   Kokudo, Norihiro ^a  

^a GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; FRESH FROZEN PLASMA; INDOCYANINE GREEN; IODINATED POPPYSEED OIL; PROTHROMBIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD SAMPLING; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG WITHDRAWAL; ERYTHROCYTE CONCENTRATE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; MALE; PATIENT SAFETY; PLEURA EFFUSION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RASH;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HEPATECTOMY; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PLASMA; PROTHROMBIN; SERUM ALBUMIN; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 67650729711     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2009.03.004     Document Type: Article

References (45)

1. Fuster J., Garcia-Valdecasas J.C., Grande L., et al. Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg 223 (1996) 297-302
2. Fan S.T., Lo C.M., Liu C.L., et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229 (1999) 322-330
3. Fong Y., Sun R.L., Jarnagin W., and Blumgart L.H. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229 (1999) 790-709
4. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
5. Ikai I., Arii S., Okazaki M., et al. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res 37 (2007) 676-691
6. Ishizawa T., Hasegawa K., Aoki T., et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134 (2008) 1908-1916
7. Wu C.C., Kang S.M., Ho W.M., et al. Prediction and limitation of hepatic tumor resection without blood transfusion in cirrhotic patients. Arch Surg 133 (1998) 1007-1010
8. Farges O., Malassagne B., Flejou J.F., et al. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 229 (1999) 210-215
9. Grazi G.L., Ercolani G., Pierangeli F., et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 234 (2001) 71-78
10. Margarit C., Escartin A., Castells L., et al. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl 11 (2005) 1242-1251
11. Capussotti L., Ferrero A., Vigano L., et al. Portal hypertension: contraindication to liver surgery?. World J Surg 30 (2006) 992-999
12. Jensen L.S., Kissmeyer-Nielsen P., Wolff B., and Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 348 (1996) 841-845
13. van de Watering L.M., Hermans J., Houbiers J.G., et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 97 (1998) 562-568
14. Kinoshita Y., Udagawa H., Tsutsumi K., et al. Usefulness of autologous blood transfusion for avoiding allogenic transfusion and infectious complications after esophageal cancer resection. Surgery 127 (2000) 185-192
15. Blumberg N., Chuang-Stein C., and Heal J.M. The relationship of blood transfusion, tumor staging, and cancer recurrence. Transfusion 30 (1990) 291-294
16. Yamamoto J., Kosuge T., Takayama T., et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 115 (1994) 303-309
17. Vamvakas E.C. Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion 35 (1995) 760-768
18. Torzilli G., Makuuchi M., Inoue K., et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 134 (1999) 984-992
19. Makuuchi M., Takayama T., Gunven P., et al. Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients. World J Surg 13 (1989) 644-648
20. Makuuchi M., Mori T., Gunven P., et al. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet 164 (1987) 155-158
21. Kajikawa M., Nonami T., Kurokawa T., et al. Autologous blood transfusion for hepatectomy in patients with cirrhosis and hepatocellular carcinoma: use of recombinant human erythropoietin. Surgery 115 (1994) 727-734
22. Ishizawa T., Hasegawa K., Kokudo N., et al. Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg 144 (2009) 46-51
23. Jarnagin W.R., Gonen M., Fong Y., et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236 (2002) 397-406
24. Brecher M.E., and Goodnough L.T. The rise and fall of preoperative autologous blood donation. Transfusion 42 (2001) 1618-1622
25. Rock G., Berger R., Bormanis J., et al. A review of nearly two decades in an autologous blood programme: the rise and fall of activity. Transfus Med 16 (2006) 307-311
26. Fujimoto J., Okamoto E., Yamanaka N., et al. Efficacy of autotransfusion in hepatectomy for hepatocellular carcinoma. Arch Surg 128 (1993) 1065-1069
27. Chan A.C., Blumgart L.H., Wuest D.L., et al. Use of preoperative autologous blood donation in liver resections for colorectal metastases. Am J Surg 175 (1998) 461-465
28. Park J.O., Gonen M., D'Angelica M.I., et al. Autologous versus allogeneic transfusions: no difference in perioperative outcome after partial hepatectomy. Autologous transfusion on hepatectomy outcome. J Gastrointest Surg 11 (2007) 1286-1293
29. Boulton F.E., and James V. Guidelines for policies on alternatives to allogeneic blood transfusion. 1. Predeposit autologous blood donation and transfusion. Transfus Med 17 (2007) 354-365
30. Miki A., Fujii T., Yoshikawa H., et al. A novel method of preoperative autologous blood donation with a large volume of plasma for surgery in gynecologic malignancies. Transfus Apher Sci 31 (2004) 21-28
31. Ramm G.A., and Ruddell R.G. Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. Semin Liver Dis 25 (2005) 433-449
32. Furutani T., Hino K., Okuda M., et al. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein. Gastroenterology 130 (2006) 2087-2098
33. Makuuchi M., Kosuge T., Takayama T., et al. Surgery for small liver cancers. Semin Surg Oncol 9 (1993) 298-304
34. Makuuchi M., Hasegawa H., and Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161 (1985) 346-350
35. Komatsu F., and Yoshida S. Large volume apheresis of autologous plasma and preparation of autologous fibrin glue from the plasma. Ther Apher 5 (2001) 12-16
36. Prinsen B.H., and de Sain-van der Velden M.G. Albumin turnover: experimental approach and its application in health and renal diseases. Clin Chim Acta 347 (2004) 1-14
37. de Sain-van der Velden M.G., Kaysen G.A., de Meer K., et al. Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: measurements with stable isotopes. Kidney Int 53 (1998) 181-188
38. Currie C.J., Patel T.C., McEwan P., and Dixon S. Evaluation of the future supply and demand for blood products in the United Kingdom National Health Service. Transfus Med 14 (2004) 19-24
39. Greinacher A., Fendrich K., Alpen U., and Hoffmann W. Impact of demographic changes on the blood supply: Mecklenburg-West Pomerania as a model region for Europe. Transfusion 47 (2007) 395-401
40. Sullivan M.T., Cotten R., Read E.J., and Wallace E.L. Blood collection and transfusion in the United States in 2001. Transfusion 47 (2007) 385-394
41. Blood Products Research Organization. Blood Program in Japan. http://www.bpro.or.jp/english/pdf_annual/BPRO2006.pdf Accessed January 30, 2008
42. Buelow R., Burlingham W.J., and Clayberger C. Immunomodulation by soluble HLA class I. Transplantation 59 (1995) 649-654
43. Magee C.C., and Sayegh M.H. Peptide-mediated immunosuppression. Curr Opin Immunol 9 (1997) 669-675
44. Etchason J., Petz L., Keeler E., et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 332 (1995) 719-724
45. Ginès P., Titó L., Arroyo V., et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 94 (1988) 1493-1502